Technology-Enabled Patient and Physician Activation to Enhance Skin Cancer Screening After HCT: A Randomized Controlled Trial
Journal of the National Comprehensive Cancer Network · 2026
DOI: 10.6004/jnccn.2026.7030 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2026. Verfasst von Saro H Armenian und 17 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Population Sciences, City of Hope, Duarte, CA. Hauptthemen laut MEDLINE: Skin Neoplasms, Early Detection of Cancer, Patient Participation. Die Arbeit nennt 35 Literaturangaben. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Background
Survivors of hematopoietic cell transplantation (HCT) have an increased risk of skin cancer, yet adherence to recommended skin self-examination (SSE) and annual physician skin examinations is low. Scalable strategies to improve screening in this high-risk population are needed. Patients and Methods: We conducted a randomized controlled trial of 720 adult survivors of HCT enrolled between October 30, 2020, and December 13, 2023. Participants received remotely delivered print materials and 12 educational text messages over 9 months (patient activation and education [PAE]). In the PAE plus physician activation group (PAE + Phys), providers also received educational materials and guidance on performing skin examinations. Primary outcomes were participant-reported SSE within the prior 2 months and physician skin examination within the prior 12 months, assessed at baseline and 12 months. Secondary outcomes included the number of body regions examined and skin cancer knowledge.
Results
Median age at enrollment was 61 years (range, 18–81), and the median time from HCT until enrollment was 3.1 years (range, 1.7–5.3). The proportion of participants reporting both physician skin examination and SSE increased in both groups, from 15.8% to 47.5% in the PAE group (odds ratio [OR], 4.98; 95% CI, 3.54–7.02) and from 18.0% to 52.1% in the PAE + Phys group (OR, 5.49; 95% CI, 4.03–7.50), with no significant between-group difference. SSE increased significantly in both groups, from 34.7% to 81.5% in the PAE group and from 31.5% to 79.0% in the PAE + Phys group, without no significant between-group difference. Physician skin examinations increased from 32.1% to 55.3% in the PAE group and from 33.2% to 64.8% in the PAE + Phys group, with a significantly greater increase in the PAE + Phys group ( P =.01). The mean number of body regions examined more than doubled in both groups, and skin cancer knowledge and self-efficacy improved significantly.
Conclusions
Remotely delivered interventions improved skin cancer screening among HCT survivors. Patient activation substantially increased SSE, whereas physician activation provided additional benefit for physician-performed skin examinations. These findings suggest that physician activation enhances clinician-performed screening and supports scalable survivorship care models for high-risk populations. ClinicalTrials.gov identifier: NCT04358276
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- 1Department of Population Sciences, City of Hope, Duarte, CA.
- 2Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.
- 3Department of Surgery, City of Hope, Duarte, CA.
- 4Department of Medicine, Community and Family Medicine and Population Health Sciences, Duke Cancer Institution, Duke, NC.
- 5Department of Social and Behavioral Sciences, Harvard TH Chan School of Public Health, Boston, MA.
- 6Department of Dermatology, Memorial Sloan Kettering Cancer Center, New York, NY.
Förderung
- NCI NIH HHS
Zitieren
APA
Armenian, S. H., Du, X., Bosworth, A., Rodarte, S., Balasian, E., Boyapalli, S., Herrera, C., Echevarria, M., Lindenfeld, L., Al Malki, M., Nakamura, R., Modi, B., Oeffinger, K. C., Emmons, K. M., Marghoob, A. A., Forman, S. J., Wong, F. L., & Geller, A. C. (2026). Technology-Enabled Patient and Physician Activation to Enhance Skin Cancer Screening After HCT: A Randomized Controlled Trial. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2026.7030
Vancouver
Armenian SH, Du X, Bosworth A, Rodarte S, Balasian E, Boyapalli S, et al. Technology-Enabled Patient and Physician Activation to Enhance Skin Cancer Screening After HCT: A Randomized Controlled Trial. Journal of the National Comprehensive Cancer Network. 2026. doi:10.6004/jnccn.2026.7030
BibTeX
@article{Armenian2026,
author = {Armenian, Saro H and Du, Xinyi and Bosworth, Alysia and Rodarte, Stephanie and Balasian, Elina and Boyapalli, Samhitha and Herrera, Claudia and Echevarria, Meagan and Lindenfeld, Lanie and Al Malki, Monzr and Nakamura, Ryotaro and Modi, Badri and Oeffinger, Kevin C and Emmons, Karen M and Marghoob, Ashfaq A and Forman, Stephen J and Wong, F Lennie and Geller, Alan C},
title = {Technology-Enabled Patient and Physician Activation to Enhance Skin Cancer Screening After HCT: A Randomized Controlled Trial},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2026},
doi = {10.6004/jnccn.2026.7030}
}
EUVIMED